Antiplatelet therapy is associated with a high rate of intracranial hemorrhage in patients with head injuries

BACKGROUND: Antiplatelet agents are increasingly used in cardiovascular treatment. Limited research has been performed into risks of acute and delayed traumatic intracranial hemorrhage (ICH) in these patients who sustain head injuries. Our goal was to assess the overall odds and identify factors ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Alter, Scott M, Mazer, Benjamin A, Solano, Joshua J, Shih, Richard D, Hughes, Mary J, Clayton, Lisa M, Greaves, Spencer W, Trinh, Nhat Q, Hughes, Patrick G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689589/
https://www.ncbi.nlm.nih.gov/pubmed/33294625
http://dx.doi.org/10.1136/tsaco-2020-000520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689589/
https://www.ncbi.nlm.nih.gov/pubmed/33294625
http://dx.doi.org/10.1136/tsaco-2020-000520

Ejemplares similares